Key result
China's vaccine regulatory system and quality control have enabled its vaccine products to achieve WHO prequalification and contribute to global infectious disease prevention.
This article reviews the history, development, and quality control of the Chinese vaccine industry and its global impact.
Supports expanded global vaccine access via Chinese products; leaves open need for independent outcome studies.
Through the continuous efforts of several generations, China has become one of the few countries in the world that is capable of independently addressing all the requirements by the Expanded Program on Immunization. Regulatory science is applied to continuously improve the vaccine regulatory system. Passing the prequalification by WHO has allowed Chinese vaccine products to go global. Chinese vaccine products not only secure disease prevention and control domestically but also serve the needs for international public health. This article describes the history of Chinese vaccine development, the current situation of Chinese vaccine industry and its contribution to the prevention and control of infectious diseases. We also share our experience of national quality control and vaccine regulation during the past decades. China's experience in vaccine development and quality control can benefit other countries and regions worldwide, including the developing countries.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2015) conducted a review in Infectious diseases. Vaccine development and quality control was evaluated. China's vaccine regulatory system and quality control have enabled its vaccine products to achieve WHO prequalification and contribute to global infectious disease prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: